Vol 10 Issue 10

Download PDF

Featuring

Issue Spotlight: Cell therapy downstream processing and analytics
Securing the supply chain 2024
Other articles
Webinars

Cell therapy downstream processing and analytics

Expert Insight

Interpreting the new FDA draft potency guidance: an mRNA gene modified cell therapy perspective

Damian Marshall, Kayleigh Thirlwell

2 December

Read

Review

Phase-appropriate analytical control of cell therapy manufacture in early development stages

Vaibhav Patel

11 November

Read

FastFacts

Novel isolation platform with active-release technology for scalable cell therapy manufacturing

Moen Ingrid Nyhus

18 December

Read

Infographic

Cell therapy analytics: INFOGRAPHIC

22 November

Read

Interview

Pioneering quality control in biomanufacturing of cell and gene therapies

Dhruv Sareen, Jonathan Rodriguez

5 December

Read

Troubleshooting process and analytical tool changes in an approved ATMP process

Maitane Ortiz, Marta Malo De Molina

3 December

Read

Exploring innovations in CAR-T therapy for solid tumors: the role of automated systems, analytical testing, and AI

Arindam Mitra

1 October

Read

Securing the supply chain 2024

Expert Insight

Operations strategy for a scalable CGT supply chain: key CXO insights

Shesh Sharma, Tim Sirichoke, Edward Ballesteros

2 December

Read

Interview

Supply chain sourcing and sustainability strategies for cell therapy and advanced biomaterial products

Raj Joshi

4 November

Read

Journal articles

Innovator Insight

Next-generation risk mitigation in the temperature-controlled supply chain for advanced therapies with ISO 21973 compliance

Edward Grimley, Leanne Kodsmann

4 December

Read

Navigating the opportunities and challenges in analytical development of flowcytometry for T cell therapy

Therese Choquette, Minh Ngoc Duong

25 November

Read

FastFacts

Redefining the economics of upstream mAb and viral vector bioprocessing: how process intensification boosts productivity

Rachel Legmann

30 October

Read

Webinar Digest

Accelerating gene therapy downstream process development through DoE and scalable chromatography

Tim Schroeder

7 November

Read

Enhancing CAR-T therapy development: harnessing cell selection flexibility

Tamara Laskowski, Nuala Trainor

2 October

Watch

Advancing TCR-based therapies: discovery, analysis, and QC of Ag-specific T cells targeting solid cancers

Marc Schuster, Marek Wieczorek

17 October

Watch

Application of CGE in cell and gene therapy

Ryan Hylands, Luiza Chrojan

22 October

Watch

Meeting manufacturing demand: robust scale-up of an AAV suspension process to 1,000L

Qingrui You, Peiqing Zhang

29 October

Watch

Optimizing for the future: streamlining the production of T cell-based immunotherapies

Paula Lam, Soong Poh Loong

30 October

Watch

Interferometric light microscopy for rapid virus titering and characterization of lipid nanoparticle preparations

Ben Josey

31 October

Watch

Comparing ultracentrifugation versus AEX for successful AAV purification

Thomas Guarinoni

5 November

Watch

Industry highlights: switching from manual to automated hematopoietic stem cell (HSC) gene engineering

A Marques Gomes, A Rubio Gomes, U Bissels et al.

6 November

Watch

How to use AI and machine learning in cell therapy process development

Alex Sargent

13 November

Watch

When does outsourcing autologous collection center qualification and the cell therapy supply chain make sense?

A Hines, J Newman, M van Houten

14 November

Watch

Process in the product: a new analytical tool for AAV production optimization and monitoring

Blaž Bakalar, Ivana Petrović Koshmak

19 November

Watch

Accelerating AAV production: optimizing compound identification and process parameters

Keara Sutherland, Jean-Marc Guedon

20 November

Watch

Advances in the separation and analysis of AAV-based gene delivery vectors

Jukka Kervinen, Yuliya McAnany

21 November

Watch

Meeting manufacturing demand: robust scale-up of an AAV suspension process to 1,000L

Qingrui You, Peiqing Zhang

26 November

Watch

Revolutionizing upstream gene therapy manufacturing with nanofiber microcarriers

J Counsell, L Chirica, L Mellby

27 November

Watch

CELL AND GENE THERAPY INSIGHTS

November 2024 Issue

Vol 10 Issue 10

Featuring

SPOTLIGHT

Cell therapy downstream processing and analytics

Expert Insight

Interpreting the new FDA draft potency guidance: an mRNA gene modified cell therapy perspective

Review

Phase-appropriate analytical control of cell therapy manufacture in early development stages

FastFacts

Novel isolation platform with active-release technology for scalable cell therapy manufacturing

Infographic

Cell therapy analytics: INFOGRAPHIC

Interview

Pioneering quality control in biomanufacturing of cell and gene therapies

Troubleshooting process and analytical tool changes in an approved ATMP process

Exploring innovations in CAR-T therapy for solid tumors: the role of automated systems, analytical testing, and AI

Supply Chain FOCUS

Securing the supply chain 2024

Expert Insight

Operations strategy for a scalable CGT supply chain: key CXO insights

Interview

Supply chain sourcing and sustainability strategies for cell therapy and advanced biomaterial products

Journal articles

Innovator Insight

Next-generation risk mitigation in the temperature-controlled supply chain for advanced therapies with ISO 21973 compliance

Navigating the opportunities and challenges in analytical development of flowcytometry for T cell therapy

FastFacts

Redefining the economics of upstream mAb and viral vector bioprocessing: how process intensification boosts productivity

Webinar Digest

Accelerating gene therapy downstream process development through DoE and scalable chromatography

Webinars

﻿﻿Enhancing CAR-T therapy development: harnessing cell selection flexibility

Advancing TCR-based therapies: discovery, analysis, and QC of Ag-specific T cells targeting solid cancers

Application of CGE in cell and gene therapy

Meeting manufacturing demand: robust scale-up of an AAV suspension process to 1,000L

﻿﻿Optimizing for the future: streamlining the production of T cell-based immunotherapies

Interferometric light microscopy for rapid virus titering and characterization of lipid nanoparticle preparations ﻿

Comparing ultracentrifugation versus AEX for successful AAV purification

Industry highlights: switching from manual to automated hematopoietic stem cell (HSC) gene engineering

How to use AI and machine learning in cell therapy process development

When does outsourcing autologous collection center qualification and the cell therapy supply chain make sense?

Process in the product: a new analytical tool for AAV production optimization and monitoring

Accelerating AAV production: optimizing compound identification and process parameters

Advances in the separation and analysis of AAV-based gene delivery vectors

Meeting manufacturing demand: robust scale-up of an AAV suspension process to 1,000L

Revolutionizing upstream gene therapy manufacturing with nanofiber microcarriers

Enhancing CAR-T therapy development: harnessing cell selection flexibility

Optimizing for the future: streamlining the production of T cell-based immunotherapies

Interferometric light microscopy for rapid virus titering and characterization of lipid nanoparticle preparations